1. Home
  2. VWAV vs ACOG Comparison

VWAV vs ACOG Comparison

Compare VWAV & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VWAV
  • ACOG
  • Stock Information
  • Founded
  • VWAV 2024
  • ACOG 2000
  • Country
  • VWAV United States
  • ACOG Canada
  • Employees
  • VWAV N/A
  • ACOG N/A
  • Industry
  • VWAV Computer Software: Prepackaged Software
  • ACOG
  • Sector
  • VWAV Technology
  • ACOG
  • Exchange
  • VWAV Nasdaq
  • ACOG Nasdaq
  • Market Cap
  • VWAV 162.2M
  • ACOG 149.0M
  • IPO Year
  • VWAV N/A
  • ACOG N/A
  • Fundamental
  • Price
  • VWAV $13.39
  • ACOG $6.60
  • Analyst Decision
  • VWAV
  • ACOG Strong Buy
  • Analyst Count
  • VWAV 0
  • ACOG 1
  • Target Price
  • VWAV N/A
  • ACOG $18.00
  • AVG Volume (30 Days)
  • VWAV 342.9K
  • ACOG 94.6K
  • Earning Date
  • VWAV 11-26-2025
  • ACOG 11-14-2025
  • Dividend Yield
  • VWAV N/A
  • ACOG N/A
  • EPS Growth
  • VWAV N/A
  • ACOG N/A
  • EPS
  • VWAV N/A
  • ACOG N/A
  • Revenue
  • VWAV N/A
  • ACOG $4,586,341.00
  • Revenue This Year
  • VWAV N/A
  • ACOG N/A
  • Revenue Next Year
  • VWAV N/A
  • ACOG $101.16
  • P/E Ratio
  • VWAV N/A
  • ACOG N/A
  • Revenue Growth
  • VWAV N/A
  • ACOG N/A
  • 52 Week Low
  • VWAV $2.06
  • ACOG $3.75
  • 52 Week High
  • VWAV $14.05
  • ACOG $11.54
  • Technical
  • Relative Strength Index (RSI)
  • VWAV N/A
  • ACOG 36.62
  • Support Level
  • VWAV N/A
  • ACOG $6.55
  • Resistance Level
  • VWAV N/A
  • ACOG $7.05
  • Average True Range (ATR)
  • VWAV 0.00
  • ACOG 0.46
  • MACD
  • VWAV 0.00
  • ACOG 0.01
  • Stochastic Oscillator
  • VWAV 0.00
  • ACOG 6.83

About VWAV VisionWave Holdings Inc. Common Stock

VisionWave Holdings Inc is engaged in revolutionizing defense capabilities by integrating artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. Its innovations range from high-resolution radars and vision systems to radio frequency (RF) sensing technologies are seeking to redefine operational efficiency and precision for military and homeland security applications globally.

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: